This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Whitehead Institute for Biomedical Research, Cornell University. Active years: 2000-2008.
Company Filing History:
3 out of 317 
1 out of 2,948 
Years Active: 2000-2008
Title: Min Lu: Innovator in HIV Research
Introduction
Min Lu is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of HIV research. He holds a total of 4 patents that focus on innovative methods for combating HIV and other enveloped viruses. His work has the potential to lead to breakthroughs in vaccine development and therapeutic strategies.
Latest Patents
Among his latest patents is the invention titled "Core structure of gp41 from the HIV envelope glycoprotein." This patent describes the crystal structure of the α-helical domain of the gp41 component of the HIV-1 envelope glycoprotein, which represents the core of fusion-active gp41. It also outlines methods for identifying and designing drugs that inhibit gp41 function. Another notable patent is "Antigen for developing neutralizing antibodies to human immunodeficiency virus." This invention provides polypeptides that comprise a stabilized trimer of the carboxyl-terminal core region of the ectodomain of enveloped viruses, such as HIV. These polypeptides are useful as vaccines against enveloped viruses and include methods for vaccinating individuals to prevent or treat HIV infection.
Career Highlights
Min Lu has worked at prestigious institutions, including the Whitehead Institute for Biomedical Research and Cornell Research Foundation Inc. His research has significantly advanced the understanding of HIV and has contributed to the development of potential vaccines and therapeutic agents.
Collaborations
Throughout his career, Min Lu has collaborated with notable colleagues, including David C. Chan and Deborah Fass. These collaborations have enriched his research and expanded the impact of his inventions.
Conclusion
Min Lu's innovative work in HIV research exemplifies the critical role of inventors in advancing medical science. His patents not only contribute to the understanding of HIV but also pave the way for future developments in vaccine technology.